IMNN NASDAQ
Lawrenceville, NJ 08648
US
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Tardugno Michael H | A-Award | 7,169 | $1.41 | 2026-09-25 |
| Lindborg Stacy | A-Award | 6,697 | $1.41 | 2026-09-25 |
| Faller Douglas Vince | A-Award | 4,390 | $1.41 | 2026-09-25 |
| Tardugno Michael H | A-Award | 5,824 | $1.47 | 2026-09-11 |
| Lindborg Stacy | A-Award | 5,504 | $1.47 | 2026-09-11 |